Skip to main content
Helixmith Co., Ltd logo

Helixmith Co., Ltd — Investor Relations & Filings

Ticker · 084990 ISIN · KR7084990001 KO Manufacturing
Open in API
Filings indexed 508 across all filing types
Latest filing 2020-02-10 Capital/Financing Update
Country KR South Korea
Listing KO 084990

About Helixmith Co., Ltd

https://www.helixmith.com/

Helixmith is a biotechnology company specializing in the research and development of gene therapies. Established in 1996, the company focuses on creating innovative biopharmaceuticals for diseases with significant unmet medical needs. Its core activities revolve around an extensive pipeline of next-generation gene therapy products. The primary therapeutic areas of focus include neurological and cardiovascular disorders, such as peripheral artery disease and coronary artery disease. Helixmith manages a comprehensive range of capabilities, from discovery and preclinical studies to clinical development of its drug candidates.

Recent filings

Filing Released Lang Actions
단기차입금증가결정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory announcement regarding a decision to increase short-term borrowings (단기차입금증가결정). It details the amount, purpose (repayment of convertible bonds), and board approval date. This falls under the category of financing and capital structure updates, which is best classified as CAP (Capital/Financing Update).
2020-02-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Financial Investment Services and Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements of major shareholders (specifically Kim Sun-young and related parties) of Helixmith. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-01-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in share ownership, and collateral agreements of major shareholders (Kim Sun-young and related parties) of Helixmith. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-01-03 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document tracks changes in share ownership by major shareholders and their special relations. It is not an annual report, earnings release, or announcement, but a specific disclosure of shareholding status and changes, which falls under the 'Major Shareholding Notification' category.
2019-12-27 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding the suspension of share registration (closing of the shareholder register) for the purpose of determining shareholders eligible to vote at the 24th Annual General Meeting. It does not contain the full report or proxy materials themselves, but rather serves as a formal regulatory announcement of a corporate action. Given it does not fit into specific categories like dividend announcements or share buybacks, it falls under the general regulatory filing category.
2019-12-16 Korean
기타경영사항(특허권취득)(자율공시)(간세포 성장인자의 둘 이상의 이형체를 이용한 근위축성 측삭경화증(ALS) 예방 또는 치료용 조성물)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) from Helixmith regarding the acquisition of a patent for a pharmaceutical composition for treating Amyotrophic Lateral Sclerosis (ALS). It details the patent name, content, holder, and utilization plan. Since this is a regulatory announcement regarding a specific corporate event (patent acquisition) that does not fit into financial reporting, M&A, or other specific categories, it is classified as a general regulatory filing.
2019-12-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.